Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 4 of 4 entries
Sorted by: Best Match Show Resources per page
How to assimilate the tsunami of immune checkpoints inhibitors data into clinical practice?.

Current opinion in oncology

Castelo-Branco L, Aspeslagh S, Kotecki N, Awada A.
PMID: 31335831
Curr Opin Oncol. 2019 Sep;31(5):420-423. doi: 10.1097/CCO.0000000000000563.

PURPOSE OF REVIEW: Immune checkpoint inhibitors (ICIs) are rapidly changing practice across different tumor settings. With this article, we reflect on how to assimilate the tsunami of ICIs data into clinical practice.RECENT FINDINGS: A tremendous increase on approvals, number...

Cite
Castelo-Branco L, Aspeslagh S, Kotecki N, et al. How to assimilate the tsunami of immune checkpoints inhibitors data into clinical practice?. Curr Opin Oncol. 2019;31(5):420-423doi: 10.1097/CCO.0000000000000563.
Castelo-Branco, L., Aspeslagh, S., Kotecki, N., & Awada, A. (2019). How to assimilate the tsunami of immune checkpoints inhibitors data into clinical practice?. Current opinion in oncology, 31(5), 420-423. https://doi.org/10.1097/CCO.0000000000000563
Castelo-Branco, Luís, et al. "How to assimilate the tsunami of immune checkpoints inhibitors data into clinical practice?." Current opinion in oncology vol. 31,5 (2019): 420-423. doi: https://doi.org/10.1097/CCO.0000000000000563
Castelo-Branco L, Aspeslagh S, Kotecki N, Awada A. How to assimilate the tsunami of immune checkpoints inhibitors data into clinical practice?. Curr Opin Oncol. 2019 Sep;31(5):420-423. doi: 10.1097/CCO.0000000000000563. PMID: 31335831.
Copy Download .nbib Format: NLM
Advancing cancer immunotherapy: a vision for the field.

Genome medicine

de Miranda NFCC, Trajanoski Z.
PMID: 31358048
Genome Med. 2019 Jul 29;11(1):51. doi: 10.1186/s13073-019-0662-6.

No abstract available.

Cite
de Miranda NFCC, Trajanoski Z. Advancing cancer immunotherapy: a vision for the field. Genome Med. 2019;11(1):51doi: 10.1186/s13073-019-0662-6.
de Miranda, N. F. C. C., & Trajanoski, Z. (2019). Advancing cancer immunotherapy: a vision for the field. Genome medicine, 11(1), 51. https://doi.org/10.1186/s13073-019-0662-6
de Miranda, Noel F C C, and Trajanoski, Zlatko. "Advancing cancer immunotherapy: a vision for the field." Genome medicine vol. 11,1 (2019): 51. doi: https://doi.org/10.1186/s13073-019-0662-6
de Miranda NFCC, Trajanoski Z. Advancing cancer immunotherapy: a vision for the field. Genome Med. 2019 Jul 29;11(1):51. doi: 10.1186/s13073-019-0662-6. PMID: 31358048; PMCID: PMC6661948.
Copy Download .nbib Format: NLM
Future shock: embracing disruption in the immunotherapy revolution.

The American journal of managed care

Alvarnas J.
PMID: 29689140
Am J Manag Care. 2018 Feb;24(2):SP34.

No abstract available.

Cite
Alvarnas J. Future shock: embracing disruption in the immunotherapy revolution. Am J Manag Care. 2018;24(2):SP34
Alvarnas, J. (2018). Future shock: embracing disruption in the immunotherapy revolution. The American journal of managed care, 24(2), SP34.
Alvarnas, Joseph. "Future shock: embracing disruption in the immunotherapy revolution." The American journal of managed care vol. 24,2 (2018): SP34.
Alvarnas J. Future shock: embracing disruption in the immunotherapy revolution. Am J Manag Care. 2018 Feb;24(2):SP34. PMID: 29689140.
Copy Download .nbib Format: NLM
Introduction to the Special Issue: Nanomaterials in Immunology.

Molecular immunology

Mintern JD, Johnston APR.
PMID: 29776651
Mol Immunol. 2018 Jun;98:1. doi: 10.1016/j.molimm.2018.04.012.

No abstract available.

Cite
Mintern JD, Johnston APR. Introduction to the Special Issue: Nanomaterials in Immunology. Mol Immunol. 2018;98:1doi: 10.1016/j.molimm.2018.04.012.
Mintern, J. D., & Johnston, A. P. R. (2018). Introduction to the Special Issue: Nanomaterials in Immunology. Molecular immunology, 981. https://doi.org/10.1016/j.molimm.2018.04.012
Mintern, Justine D, and Johnston, Angus P R. "Introduction to the Special Issue: Nanomaterials in Immunology." Molecular immunology vol. 98 (2018): 1. doi: https://doi.org/10.1016/j.molimm.2018.04.012
Mintern JD, Johnston APR. Introduction to the Special Issue: Nanomaterials in Immunology. Mol Immunol. 2018 Jun;98:1. doi: 10.1016/j.molimm.2018.04.012. PMID: 29776651.
Copy Download .nbib Format: NLM
Showing 1 to 4 of 4 entries